Introduction
Niemann-Pick disease type C (NPC) is an autosomal recessive lipid storage disorder that is characterized by endosomal accumulation of low-density lipoprotein (LDL)-derived cholesterol (Patterson et al., 2001) and is caused by mutations in NPC1 or NPC2 (Carstea et al., 1997; Naureckiene et al., 2000) . NPC1 is a membrane protein that resides primarily in the late endosome (Higgins et al., 1999) , whereas NPC2 is a soluble protein that resides primarily in the lysosome (Vanier and Millat, 2004) . These two proteins have been shown to function in the same endosomal cholesterol efflux pathway (Sleat et al., 2004) . However, it is not clear how they interact with each other.
Solution of the human NPC1 membrane topology revealed a 1278 amino acid protein with 13 transmembrane domains and a sterol-sensing domain (SSD) located from transmembrane domains III to VII . Although this protein has been shown to possess a lipid permease activity and the functional significance of its SSD has been well documented (Watari et al., 1999a; Millard et al., 2005) , it is not known whether NPC1 function is regulated by cellular cholesterol. In addition to NPC1, SSDs are found in other proteins involved in the control of cellular cholesterol homeostasis: sterol regulatory element binding protein (SREBP) cleavage-activating protein (SCAP) and 3-hydroxy-3-methylglutaryl CoA reductase (HMG-CoAR), both of which reside primarily in the endoplasmic reticulum (ER). SCAP associates with the ERretention proteins, Insig-1 and Insig-2, in a sterol-dependent manner: when cells are depleted of cholesterol, SCAP, together with SREBP, is released from the Insig proteins and transported to the Golgi apparatus, where a mature, active form of SREBP is generated by proteolysis and stimulates transcription of a diverse set of genes involved in cholesterol uptake and synthesis (Yang et al., 2002; Yabe et al., 2002) . Similarly, HMG-CoAR associates with the Insig proteins in a sterol-dependent manner, but in this case, the association facilitates its ubiquitylation and subsequent degradation by the proteasome, thus shutting off endogenous cholesterol biosynthesis (Ravid et al., 2000; Sever et al., 2003a; Sever et al., 2003b) . By analogy, one might hypothesize a cholesteroldependent regulation of NPC1 function, either by its association with other proteins or by post-translational modifications.
Yeast genetic analysis has identified a number of proteins required for trafficking of endosomal proteins to the vacuole, Niemann-Pick disease type C (NPC) is an inherited lipid storage disorder caused by mutations in NPC1 or NPC2. NPC1 is a polytopic glycoprotein that contains a sterolsensing domain, whereas NPC2 is a soluble protein that contains an MD-2-like lipid-recognition domain. In the current study, we addressed the hypothesis that ubiquitylation of NPC1 might be regulated by cholesterol. We found that depletion of cellular cholesterol facilitated ubiquitylation of NPC1 expressed in COS cells. A loss-offunction mutant, NPC1(P691S), which contains an amino acid substitution in the sterol-sensing domain, failed to respond to cholesterol depletion. Another mutant, NPC1(␦ ␦LLNF), which lacks the endosomal-targeting motif, also failed to respond. SKD1(E235Q), a dominant-negative mutant of SKD1/Vps4 that inhibits disassembly of the endosomal sorting complex required for transport (ESCRT), caused an accumulation of ubiquitylated NPC1. SKD1(E235Q) associated with NPC1 on the endosomal membrane, whereas wild-type SKD1 associated with NPC1 only when cells were depleted of cholesterol. Similarly, in control human skin fibroblasts, cholesterol depletion facilitated ubiquitylation of endogenous NPC1. In patient cells that lack NPC2 function, NPC1 was ubiquitylated regardless of cellular cholesterol levels, suggesting that NPC2 is required to prevent NPC1 ubiquitylation under cholesterol-rich conditions. These results suggest that ubiquitylation of NPC1 and its association with the ESCRT complex are controlled by endosomal cholesterol levels utilizing a mechanism that involves NPC2.
collectively termed the vacuolar protein sorting (Vps) proteins. These proteins assemble on the endosomal membrane to form the protein complexes ESCRT (endosomal sorting complex required for transport) -I, -II and -III, which operate sequentially (Katzmann et al., 2001; Babst et al., 2002a; Babst et al., 2002b) . In this sorting process, ubiquitylation of an endosomal membrane protein serves as a signal for its sorting into the internal membranes of multivesicular bodies (Hicke, 2001) . Vps4 is an ATPase that exists primarily in an inactive, ADP-bound cytosolic form and its active, ATP-bound form can transiently associate with the endosomal membrane. This protein is required for disassembly of the ESCRT-III. Expression of an ATPasedeficient, dominant-negative mutant of Vps4, the E233Q mutant, results in entrapment of ubiquitylated proteins on the endosomal membrane (Babst et al., 1997; Babst et al., 1998) . Ncr1 is the yeast homolog of NPC1 and recent studies provided two lines of evidence that indicated a functional interaction between Ncr1 and Vps4. First, the targeting of Ncr1 to the vacuolar limiting membrane depends on Vps proteins, including Vps4 (Zhang et al., 2004) . Second, Ncr1-null and Vps4-null cells share the same phenotyperesistance to the ether lipid drug edelfosine (Berger et al., 2005) .
Mammalian counterparts to Vps proteins are presumed to function in a similar manner, and have been shown to be required for the ubiquitin-dependent, lysosomal transport of various membrane proteins, such as epidermal growth factor receptor (EGFR) (Bishop and Woodman, 2000; Bishop et al., 2002) , G-protein-coupled receptors (Shenoy et al., 2001 ) and the cystic fibrosis transmembrane conductance regulator (Sharma et al., 2004) . The suppressor of potassium transport growth defect protein 1, SKD1, is a mammalian ortholog of Vps4 and is a member of the N-ethylmaleimide-sensitive factor and AAA-type ATPase family (Scheuring et al., 2001) . Like Vps4 in yeasts, SKD1 shuttles between an ADP-bound cytosolic form and an ATP-bound membrane-associated form. Also, similar to Vps(E233Q), SKD1(E235Q) lacks the ATPase activity and has a dominant-negative effect when expressed in mammalian cells. Expressed SKD1(E235Q) protein disrupts endosomal trafficking and localizes to aberrant endosomes (Yoshimori et al., 2000; Fujita et al., 2003) .
Given the presence of an SSD, we hypothesized that NPC1 might be ubiquitylated by a cholesterol-dependent mechanism. Following confirmation that cellular cholesterol depletion facilitated NPC1 ubiquitylation, we pursued the hypothesis further that NPC1 interacts with the ESCRT complex.
Results
Cholesterol depletion facilitated ubiquitylation of NPC1 expressed in COS cells NPC1 ubiquitylation was examined in COS cells transfected with Flag-NPC1 and myc/His 6 -ubiquitin. 48 hours after transfection, cells were incubated either in cholesterol-rich medium [DMEM + 10% bovine calf serum (BCS)] or cholesterol-depleted medium [DMEM + 10% lipoproteindeficient serum (LPDS)] supplemented with compactin and mevalonate. When cells were incubated in the cholesteroldepleted medium, the total cellular cholesterol level decreased in a time-dependent manner to reach ~60% of the Journal of Cell Science 119 (13) control level at 12 hours. The cholesterol level was restored by supplementation with 20 g/ml LDL (Fig. 1A) . Expressed Flag-NPC1 was recovered by immunoprecipitation with antiFlag M2 agarose and the products were analyzed by immunoblotting. As expected, Flag-NPC1 was detected in the immunoprecipitation products as a broad band between 150 and 250 kDa, as a result of its extensive glycosylation (Watari et al., 1999a) . In addition, a band just below the top of the gel was often observed (for example, see Fig. 1E ), which might represent an oligomerized form of the protein.
Cholesterol depletion had little, if any, effect on the steadystate levels of the expressed proteins. However, probing with anti-myc revealed that cholesterol depletion caused conjugation of myc/His 6 -ubiquitin to Flag-NPC1 (Fig. 1B) . The positive signals were constantly detected at 6 hours and were sustained up to 24 hours. The conjugation was also demonstrated by metal affinity purification of myc/His 6 -ubiquitin. Flag-NPC1 was detectable in the affinity purification products from cholesterol-depleted cells (Fig. 1C, left panel) . Probing the affinity purification products with anti-myc showed no overall increase of ubiquitylated proteins in cholesterol-depleted cells (Fig. 1C, right panel) . To see whether the ubiquitylation was caused by overexpression of ubiquitin molecules, cells were transfected only with Flag-NPC1 construct. Probing the anti-Flag immunoprecipitation products with anti-ubiquitin P4D1 revealed conjugation of endogenous ubiquitin to Flag-NPC1 in cells depleted of cholesterol (Fig. 1D) .
Next, by using myc/His 6 -ubiquitin co-expression, we examined whether cholesterol, instead of LDL, could suppress Flag-NPC1 ubiquitylation. Supplementation of the cholesteroldepleted medium with free cholesterol caused dose-dependent suppression of Flag-NPC1 ubiquitylation (Fig. 1E) , suggesting that the ubiquitylation was a result primarily to cholesterol depletion.
To characterize Flag-NPC1 ubiquitylation further, we conducted two lines of experiments, first to examine effects of U18666A and second to examine detergent solubility of ubiquitylated Flag-NPC1. U18666A is a sterol derivative that has been shown to induce an NPC-like phenotype (Ko et al., 2001) . To see whether this compound affected Flag-NPC1 ubiquitylation, transfected cells were incubated with 2 g/ml U18666A for 12 hours. U18666A treatment at this concentration and duration caused endosomal cholesterol accumulation as revealed by filipin staining (data not shown) and, as reported previously , an increase in the steady-state levels of expressed Flag-NPC1. Despite its effects on the steady-state levels, U18666A did not affect Flag-NPC1 ubiquitylation in cholesterol-rich medium nor did it suppress Flag-NPC1 ubiquitylation in cholesterol-depleted medium (Fig. 1F) .
Cholesterol is the major constituent of raft microdomains and a part of NPC1 has been shown to associate with these domains (Garver et al., 2000) . Therefore, it was possible that cholesterol depletion changed distribution of Flag-NPC1, which might lead to its ubiquitylation. To test this possibility, we examined the levels of Flag-NPC1 and its ubiquitylated form in 1% Triton X-100-soluble and Triton X-100-insoluble fractions, since raft microdomains are preferentially recovered in the insoluble fractions (Simons and Ikonen, 1997) . Incubation for 6 hours in the cholesterol-depleted medium reduced the level of Flag-NPC1 recovered from insoluble fractions. However, ubiquitylated Flag-NPC1 was recovered both from soluble and insoluble fractions (Fig. 1G ). These data did not support the notion that Flag-NPC1 ubiquitylation was secondary to re-distribution of the protein between raft and non-raft membrane domains. Fig. 1 . Effects of cholesterol depletion on ubiquitylation of Flag-NPC1 expressed in COS cells. (A) Cellular cholesterol levels. Cells were cultured in cholesterol-rich medium (DMEM + 10% BCS) or cholesterol-depleted medium (DMEM + 10% LPDS supplemented with compactin and mevalonate) with or without LDL (20 g/ml) up to 24 hours. Concentrations of total cholesterol in cell lysates were determined as described in the Materials and Methods. Each point represents the mean of duplicated determinations obtained in a single experiment. (B) Conjugation of myc/His 6 -ubiquitin (myc/His 6 -Ubi) to Flag-NPC1. Cells were transfected with expression constructs for myc/His 6 -ubiquitin together with Flag-NPC1 or an empty vector. 48 hours after transfection, they were further cultured in the indicated medium. 0.5% CHAPS extracts were subjected to anti-Flag immunoprecipitation (IP) followed by immunoblotting (IB) with indicated antibodies. Molecular weights are given on the left (kDa). The arrowhead indicates the top of the separating gel and the asterisk indicates the heavy chain. (C) Co-purification of Flag-NPC1 with myc/His 6 -ubiquitin. After incubation in the indicated medium for 6 hours, cell extracts were subjected to affinity purification with metal resin followed by immunoblotting with indicated antibodies. (D) Conjugation of endogenous ubiquitin to Flag-NPC1. Cells were transfected with Flag-NPC1 or an empty vector, cultured in the indicated medium for 6 hours and anti-Flag IP products were analyzed by indicated antibodies. (E) Effects of exogenous cholesterol on ubiquitylation of Flag-NPC1. Cells were transfected with myc/His 6 -ubiquitin and Flag-NPC1, and cultured for 6 hours in cholesterol-rich or cholesterol-depleted medium supplemented with increasing concentrations of cholesterol. (F) Effects of U18666A. The transfected cells were cultured in the indicated medium for 12 hours in the presence or absence of U18666A. (G) Solubility of Flag-NPC1 to 1% Triton X-100. The transfected cells were cultured in the indicated medium for 6 hours. Total cell extracts (T), 1% Triton X-100-soluble (S) and Triton X-100-insoluble (I) fractions were prepared as described in the Materials and Methods. In E-G, anti-Flag immunoprecipitation products were subjected to immunoblotting with anti-Flag or anti-myc. All results shown are representative and were reproduced at least twice.
Mutant proteins Flag-NPC1(P691S) and Flag-NPC1(␦LLNF) failed to respond to cholesterol depletion
To examine the role of the SSD in the cholesterol-leveldependent ubiquitylation, myc/His 6 -ubiquitin co-expression experiments were repeated using Flag-NPC1(P691S), a lossof-function mutant that contains an amino acid substitution in its SSD (Watari et al., 1999a; Millard et al., 2005) . Anti-Flag immunoprecipitation products contained similar levels of Flag-NPC1 wild-type (wt) and P691S mutant proteins. Probing with anti-myc demonstrated that, in contrast to the wt protein, ubiquitylation of this mutant protein was barely facilitated following cholesterol depletion for 6 hours ( Fig. 2A) . To examine whether endosomal localization was required for NPC1 to undergo this modification, we examined effects of cholesterol depletion on the ␦LLNF mutant protein that lacks the C-terminal di-leucine motif and is retained in the ER (Watari et al., 1999b; Scott et al., 2004) . As in the case of the P691S mutant, ubiquitylation of this mutant protein was barely affected by cholesterol depletion (Fig. 2B) .
As a control experiment, we examined the effects of MG132, a proteasome inhibitor, on ubiquitylation of expressed proteins and found similar responses of the wt and mutant proteins. Similar to the wt protein, both P691S and ␦LLNF mutant proteins were extensively ubiquitylated in cells treated with 5 M MG132 for 6 hours ( Fig. 2) .
Effects of MG132 and leupeptin on ubiquitylation of NPC1 Ubiquitylation can serve as a signal for protein degradation, which is executed by the cytosolic proteasome or by the lysosome. In an attempt to see whether ubiquitylated NPC1 underwent proteasomal and/or lysosomal degradation, we compared effects of MG132 and the lysosomal inhibitor leupeptin on Flag-NPC1 ubiquitylation. Treatment with 5 M MG132 for 6 hours caused accumulation of ubiquitylated Flag-NPC1 and its effects were not influenced by cellular cholesterol levels. This increase in ubiquitylated Flag-NPC1 was accompanied by increased steady-state levels of Flag-NPC1, again regardless of the cholesterol levels (Fig. 3 , upper panel). Similar results were reproduced with the proteasome inhibitor lactocystin (10 M) (data not shown). By contrast, treatment with 100 M leupeptin for 6 hours did not affect ubiquitylation of Flag-NPC1 either in cholesterol-rich or cholesterol-depleted conditions, nor caused appreciable changes in the steady-state levels of the protein (Fig. 3 , lower panel). Incubation of the cells with NH 4 Cl (10 mM for 6 hours) also failed to affect ubiquitylation of Flag-NPC1 and its steadystate levels (data not shown).
Interaction between SKD1(E235Q) and NPC1
Ubiquitylation can serve as a signal for the intracellular sorting of a protein. Since NPC1 resides primarily in the late endosome, we hypothesized that NPC1 was recognized by the ESCRT complex, which plays an essential role in the lysosomal sorting of ubiquitylated endosomal proteins. To address this hypothesis, NPC1 ubiquitylation was examined in the presence of SKD1(E235Q) (Fig. 4A) , which inhibits disassembly of the ESCRT complex. When transfected cells were cultured in cholesterol-rich medium, expression of His 6 -SKD1wt did not affect ubiquitylation of Flag-NPC1, whereas expression of His 6 -SKD1(E235Q) caused a clear increase in the level of ubiquitylated Flag-NPC1 (Fig. 4B) . Given its Journal of Cell Science 119 (13) Fig. 2 . Ubiquitylation of mutant NPC proteins. COS cells were transfected with myc/His 6 -ubiquitin (myc/His 6 -Ubi) together with Flag-NPC1 constructs that encoded the wild-type (wt) or mutant proteins P691S (A) or ␦LLNF (B); the arrowhead indicates the top of the separating gel. Cells were cultured in the indicated medium for 6 hours (left panels) or treated with or without MG132 for 6 hours (right panels). In both A and B, anti-Flag immunoprecipitation (IP) products were subjected to immunoblotting (IB) with anti-Flag or anti-myc. All results shown are representative and were reproduced at least twice. effects on NPC1 ubiquitylation, we examined whether SKD1(E235Q) co-localized and could interact with NPC1. Expression of a GFP-SKD1wt construct yielded a diffuse distribution in the cytoplasm and the nucleus, and did not induce any obvious changes of intracellular structures. AntiFlag immunofluorescence revealed that Flag-NPC1 was retained in endosomes and did not co-localize with GFPSKD1wt. As reported previously (Yoshimori et al., 2000; Fujita et al., 2003) , expression of GFP-SKD1(E235Q) results in the formation of multiple aberrant vesicles that associated with the E235Q protein. Flag-NPC1 also localized to these aberrant endosomes and partially co-localized with GFP-SKD1(E235Q) (Fig. 4C) . Detection of His 6 -tagged SKD1 and Flag-NPC1 proteins yielded similar results (data not shown).
We next examined whether there was any interaction between Flag-NPC1 and SKD1 by immunoprecipitation and immunoblotting experiments. Similar levels of Flag-NPC1 were recovered by anti-Flag immunoprecipitation from cells expressing wt or E235Q mutant GFP-SKD1 protein (Fig. 4D , lanes 2 and 4). Probing the same immunoprecipitation products with anti-GFP showed that a portion of the GFP-SKD1(E235Q) protein was co-precipitated with Flag-NPC1 Results shown are the representative images obtained with a confocal microscope. Lower; affinity purification. 0.5% CHAPS extracts were prepared from cells transfected with an empty vector, His 6 -SKD1wt or E235Q constructs. His 6 -tagged proteins were affinity purified with metal affinity resin and were analyzed by immunoblotting with the indicated antibodies. Cell extracts (IN; input) were loaded on lanes 1, 3 and 5, and corresponding affinity-purification products (AP) were loaded on lanes 2, 4 and 6. (F) In vitro interaction between GST-SKD1 and Flag-NPC1. GST-fused proteins, as shown in the schematic representations, were expressed in E. coli and immobilized on glutathione sepharose (left, CBB: Coomassie Blue staining). 0.5% CHAPS extracts (input) were prepared from COS cells expressing Flag-NPC1. Cell extracts were incubated with immobilized GSTfused proteins in the absence or presence of 0.5 mM ADP, ATP or ATP␥s. Bound proteins were eluted with glutathione and analyzed by anti-Flag immunoblotting (right). Molecular weights are given on the left (kDa). All results shown are representative and were reproduced at least twice.
(lane 4), whereas no GFP-SKD1wt could be co-precipitated (lane 2). These results were confirmed by probing with anti-SKD1 (lanes 2 and 4). Of note, in addition to GFP-SKD1 at 78 kDa, the anti-SKD1 antibody detected the endogenous SKD1 at 52 kDa (lanes 1, 3, 5 and 7), which, as expected, was not co-precipitated with Flag-NPC1 (lanes 2, 4 and 6). Further confirmation of the results was provided by repeating the above experiments using extracts from cells expressing His 6 -tagged SKD1 proteins (data not shown).
Because CHO cells express a readily detectable level of NPC1 , we used this cell line to test whether SKD1(E235Q) could interact with endogenous NPC1 (Fig. 4E) . Unlike Flag-NPC1 expressed in COS cells, endogenous NPC1 in CHO cells exhibited relatively sharp bands with molecular weights of 170 and 200 kDa. Expression of GFP-SKD1(E235Q), but not GFP-SKD1, again caused the formation of aberrant endosomes containing the mutant protein. These results could be reproduced using His 6 -tagged SKD1 proteins (data not shown). When the His 6 -tagged SKD1 protein was affinity purified from cell extracts using metal affinity chromatography, a portion of endogenous NPC1 was co-purified with His 6 -SKD1(E235Q) (Fig. 4E, lane 6 ), but not with His 6 -SKD1wt (lane 4).
Although the above findings suggested an interaction between NPC1 and the ATP-bound, membrane-associated form of SKD1, it was possible that this interaction was secondary to the formation of the aberrant vesicles that are known to accumulate various endosomal proteins (Yoshimori et al., 2000; Fujita et al., 2003) . To address this question, we examined whether NPC1 could bind to SKD1 in vitro (Fig. 4F) . Human wt and E235Q mutant SKD1 proteins were expressed as GST-fusion proteins in Escherichia coli, whereas Flag-NPC1 was expressed and detergent solubilized from COS cells. GST-SKD1 proteins were immobilized on glutathione sepharose and incubated with 0.5% CHAPS-solubilized cell extracts. Flag-NPC1 bound to the sepharose with binding to both GST-SKD1wt and the E235Q mutant dependent on the presence of ATP or ATP␥s. No binding could be detected in the presence of ADP.
Cholesterol depletion facilitated the interaction between NPC1 and wt SKD1 The above findings indicated that NPC1 could interact with the ATP-bound, membrane-associated form of SKD1. To address whether this interaction occurred in cholesterol-depleted cells, cells expressing Flag-NPC1 and His 6 -SKD1wt were cultured in cholesterol-depleted medium. In these cells, there was an increase in the amount of His 6 -SKD1wt that co-precipitated with Flag-NPC1, as compared with the level in cells cultured in cholesterol-rich medium (Fig. 5A ). This co-precipitation was largely suppressed by LDL supplementation of cholesterol-depleted medium.
These findings suggested that at least a part of His 6 -SKD1wt was recruited to the endosomes of cholesterol-depleted cells. To confirm this, Opti-prep fractionation of cell homogenates was carried out to detect the membrane-associated form of SKD1 (Fig. 5B) . Following fractionation, the endosomal marker protein lamp2 was mainly distributed in fractions 4-7 and cholesterol depletion caused a leftward shift of this distribution to fractions 4-6. Similar to lamp2, Flag-NPC1 was distributed in fractions 3-8 and in 3-7 for the cholesterol-rich and cholesterol-depleted cell homogenates, respectively. Cholesterol depletion caused a more significant change in the distribution of His 6 -SKD1wt. In cells cultured in cholesterolrich medium, His 6 -SKD1wt was exclusively recovered in the bottom fraction 12, whereas in cells cultured using cholesteroldepleted medium, this protein was also recovered in fractions Journal of Cell Science 119 (13) 3-6. As a control experiment, we examined the distribution of His 6 -SKD1(E235Q) and found that this protein was distributed in fractions 3-6 regardless of the cellular cholesterol levels (data not shown).
To confirm the endosomal recruitment of SKD1 in cholesterol-depleted cells further, we examined the intracellular localization of GFP-SKD1wt. As shown in Fig.  4C and Fig. 5C (left panel) , when cells expressing Flag-NPC1 and GFP-SKD1wt were cultured in cholesterol-rich medium, GFP-SKD1wt was cytosolic and did not co-localize with endosomal Flag-NPC1. When these cells were cultured in cholesterol-depleted medium, GFP-SKD1wt was concentrated on the rim of enlarged endosomes where it co-localized with Flag-NPC1 (Fig. 5C, right panel) .
Cholesterol depletion facilitated ubiquitylation of endogenous NPC1 and its association with SKD1 in controls but not in NPC human skin fibroblasts The above findings indicated that cholesterol depletion induced ubiquitylation of NPC1 and its interaction with SKD1, when these proteins were expressed in COS cells. To examine whether cholesterol depletion had similar effects on endogenous NPC1 and SKD1, we used primary-cultured human skin fibroblasts from a control subject H34 and an NPC patient UCH (homozygous for the NPC1 H510P mutation). As reported previously , UCH cells expressed undetectable levels of NPC1 (Fig. 6A ), and were included as a negative control. Probing of H34 cell extracts with anti-NPC1 showed that, like CHO cells, these cells contained two species of NPC1 -a major band at 170 kDa and a minor band at 200 kDa -and that cholesterol depletion caused a marginal decrease in the steady-state levels of the NPC1 protein (Fig. 6A ). Since immunoprecipitation of the endogenous NPC1 protein was unsuccessful, we employed anti-ubiquitin (P4D1) immunoprecipitation to evaluate the extent of NPC1 ubiquitylation (Fig. 6B) . Probing with anti-NPC1 antibody showed that NPC1 was absent in the anti-ubiquitin immunoprecipitation products from cells cultured in cholesterol-rich medium, but was clearly detectable in the immunoprecipitation products from cells depleted of cholesterol. Probing of cell extracts with anti-ubiquitin antibody showed no overall increase of ubiquitylated proteins caused by cholesterol depletion (data not shown). The specificity of anti-NPC1 signals was confirmed by their absence in the immunoprecipitation products from UCH cells. Probing with anti-SKD1 antibody showed that cholesterol depletion increased the level of SKD1 contained in the anti-ubiquitin immunoprecipitation products from H34 cells. By contrast, cholesterol depletion did not alter the levels of SKD1 in the immunoprecipitation products from UCH cells.
Next, using Opti-prep fractionation, the recruitment of SKD1 to the endosomes of cholesterol-depleted cells was examined (Fig. 6C) . Both lamp2 and NPC1 in membrane fractions of H34 cells were recovered in fractions 3-5 and, similar to the observations in COS cells (Fig. 5B) , cholesterol depletion caused a leftward shift of this distribution to fractions 2 and 3. SKD1 was not recovered in these fractions when cells were cultured in cholesterol-rich medium, but was recovered in fractions 2 and 3 when cells were depleted of cholesterol.
In membrane fractions of UCH cells, lamp2 was recovered in fractions 2 and 3 and, unlike in H34 cells, cholesterol depletion caused a rightward shift of this distribution to fractions 3-5. As Fig. 6 . Effects of cholesterol depletion on ubiquitylation of endogenous NPC1 and its interaction with SKD1 in human skin fibroblasts. Cells from a control subject or patients with NPC1 or NPC2 disease were cultured in cholesterol-rich or cholesteroldepleted medium for 16 hours. (A) Expression of NPC1 and SKD1. 0.5% CHAPS extracts were analyzed by immunoblotting (IB) with antibodies against the indicated proteins. (B) NPC1 ubiquitylation and its association with SKD1. 0.5% CHAPS extracts were subjected to anti-ubiquitin (P4D1) immunoprecipitation (IP) and the immunoprecipitated products were analyzed by immunoblotting with the indicated antibodies. Molecular weights are given on the left (kDa). (C) Cell fractionation. Membrane fractions (100,000 g pellet) of cell homogenates were fractionated on an Opti-prep gradient. All results shown are representative and were reproduced at least twice. expected, NPC1 was absent in UCH cell fractions and, again unlike in H34 cells, SKD1 was not at all recovered in these fractions regardless of the cellular cholesterol levels.
It was possible that this lack of SKD1 recruitment in UCH cells was simply because the cells lacking NPC1 could not be effectively depleted of cholesterol. To address this issue, UCH cells were cultured in cholesterol-depleted medium for 3 days. This treatment abolished endosomal cholesterol accumulation as revealed by filipin staining but again failed to induce endosomal recruitment of SKD1 (data not shown). These findings suggested that the negative results in UCH cells were not a result of ineffective cholesterol depletion, but a result of the absence of NPC1.
Finally, to see if NPC2 is involved in the regulation of NPC1 ubiquitylation, we repeated the same experiments using cells from a patient with NPC2 disease (90031, homozygous for the NPC2 E20X mutation), which lack NPC2 function. Our previous analysis using 0.4% SDS extracts from 100,000 g membrane preparations revealed an increased amount of NPC1 in the NPC2 cells as compared with control cells (Millat et al., 2001a) . However, anti-NPC1 blotting of 0.5% CHAPS extracts showed comparable levels of NPC1 between H34 and the NPC2 cells (Fig. 6A) , suggesting reduced solubility of NPC1 in these cells to this detergent. Nonetheless, anti-ubiquitin immunoprecipitation experiments using the 0.5% CHAPS extracts revealed distinct patterns of NPC1 ubiquitylation. A part of NPC1 was ubiquitylated in these cells regardless of the cholesterol levels (Fig. 6B ). This ubiquitylation of NPC1 was accompanied by the presence of SKD1 in the anti-ubiquitin immunoprecipitation products from cells cultured either in cholesterol-rich or cholesterol-depleted medium (Fig. 6B) . Opti-prep fractionation of the NPC2 cells showed a distinct distribution pattern of SKD1. Both lamp2 and NPC1 were recovered in fractions 2 and 3 from cells cultured in cholesterol-rich medium and, unlike in H34 cells, cholesterol depletion caused a rightward shift of this distribution to fractions 3-5. In contrast to H34 cells, SKD1 co-localized with NPC1 regardless of the cellular cholesterol levels and it was present in fractions 2 and 3, and in 3-5, from cells cultured in cholesterol-rich and cholesterol-depleted medium, respectively (Fig. 6C) . Similar results were obtained by using another NPC2 cell strain 88082 (data not shown), suggesting that they are a common feature of NPC2-deficient cells.
Discussion
The biochemical mechanism and physiological implication of the cholesterol-dependent control of protein ubiquitylation has so far been documented only for HMG-CoAR, a rate-limiting enzyme of cholesterol biosynthesis localized in the ER. Briefly, repletion of cellular cholesterol facilitates association of HMGCoAR with the Insig proteins, which in turn accelerates its ubiquitylation and proteasomal degradation (Ravid et al., 2000; Sever et al., 2003a; Sever et al., 2003b) . We have shown in the current study that ubiquitylation of NPC1 was induced by depletion of cellular cholesterol, but not by its repletion. It is currently unknown how cholesterol exerts opposite effects on NPC1 and HMG-CoAR, the two proteins that share SSDs. These opposite effects possibly result from differences in their subcellular locations and/or the nature of the interacting proteins involved in the regulatory processes. We have shown that two kinds of mutant NPC1 proteins -P691S and ␦LLNF -failed to respond to cholesterol depletion (Fig. 2) . The negative response of the P691S mutant suggested that an intact SSD was required for NPC1 to undergo this modification, whereas the negative response of the ␦LLNF mutant suggested that the modification took place in the endosomes, where NPC1 normally resides.
Ubiquitylation of a protein can serve as a signal for its degradation or intracellular sorting. Unlike the case of HMGCoAR, cholesterol-level-dependent NPC1 ubiquitylation does not appear to serve a major role in the control of protein degradation, since cholesterol depletion caused little effect on the steady-state levels of expressed Flag-NPC1 (Fig. 1) . Its effect on the steady-state levels of endogenous NPC1 was also marginal (Fig. 6) . This finding agrees with the observation by Zhang et al. (Zhang et al., 2001 ), who found negative effects of cholesterol depletion on the NPC1 protein levels in human skin fibroblasts. Ubiquitylated proteins can be degraded either by the lysosome or by the proteasome in the cytosol. The negative effects of the lysosomal inhibitor leupeptin on ubiquitylation of NPC1 and its steady-state levels (Fig. 3) argue against a role of the lysosome in NPC1 degradation. Our findings with the proteasomal inhibitor MG132 suggest that, like HMG-CoAR, NPC1 does undergo ubiquitylation and proteasomal degradation, but these events appear to be independent to cellular cholesterol levels. MG132 caused accumulation of ubiquitylated Flag-NPC1 and increased its steady-state levels regardless of cellular cholesterol levels (Fig.  3) . MG132 induced ubiquitylation of the P691S and ␦LLNF mutant proteins that failed to respond to cholesterol depletion (Fig. 2) . Therefore, as for the role of the proteasome in NPC1 degradation, we hypothesize that NPC1 undergoes ubiquitylation and proteasomal degradation because of protein misfolding, but not because of cholesterol depletion, and that the quality control takes place in the ER, but not in the endosome.
Our findings on the interaction between NPC1 and SKD1 suggest that ubiquitylation of NPC1 induced by cholesterol depletion serves as a sorting signal. The interaction between NPC1 and the ATP-bound, membrane-associated form of SKD1 was indicated by co-localization and co-precipitation of NPC1 and SKD1(E235Q) (Fig. 4C-E) . This interaction only occurs with the ATP-bound form of SKD1, as shown by the in vitro binding of NPC1 to immobilized SKD1, which depended on the presence of ATP/ATP␥s (Fig. 4F) . Importantly, cholesterol depletion induced an interaction between NPC1 and wt SKD1, which presumably was in the ATP-bound, membrane-associated form (Fig. 5) . The effect of cholesterol depletion on NPC1 ubiquitylation was also demonstrated for the endogenous protein in human skin fibroblasts (Fig. 6B ) and, again, this ubiquitylation was accompanied by recruitment of SKD1 to the endosomal fractions (Fig. 6C) . In yeast, Vps4 is required for disassembly of the ESCRT-III, which contains other Vps proteins Vps2, Vps20, Vps24 and Vps32/Snf7 (Babst et al., 2002a) . Mammalian counterparts to these proteins have recently been identified (Fujita et al., 2004; Peck et al., 2004; Yan et al., 2005) . Our findings suggest that NPC1 interacted with these proteins in the presence of SKD1(E235Q) or in cells depleted of cholesterol.
Two lines of questions can be addressed regarding the interaction between NPC1 and the ESCRT complex. First, how is ubiquitylated NPC1 recognized by the ESCRT complex?
Tsg101 is a mammalian ortholog of yeast Vps23 and has been shown to bind directly to ubiquitylated EGFR (Bishop and Woodman, 2001; Bishop et al., 2002) . We tested whether Flag-NPC1 interacted with endogenous Tsg101 in COS cells, but could not detect any interaction between these two proteins. Therefore, it is likely that NPC1 is recognized by the ESCRT complex in a manner that is different to EGFR. Second, what is the role of the ESCRT complex in the intracellular sorting of NPC1? NPC1 is primarily localized on the late endosome and can transiently associate with cholesterol-enriched lysosomes (Higgins et al., 1999) . The ESCRT complex plays a crucial role in the sorting of ubiquitylated proteins form the endosome to the lysosome through multivesicular bodies (Bishop and Woodman, 2000; Yoshimori et al., 2000; Bishop et al., 2002; Fujita et al., 2003) and, in Vps mutant yeast cells, Ncr1 is trapped in the pre-vacuolar compartments (Zhang et al., 2004) , which correspond to mammalian endosomes. Therefore, it is likely that the ESCRT complex is required for the sorting of NPC1 from the late endosome to the lysosome. At least in yeast, it has been shown that the entry of the ubiquitylated protein to multivesicular bodies is preceded by de-ubiquitylation of the protein (Babst et al., 2002a) . Given the effects of cholesterol depletion, we propose that the sorting of NPC1 is regulated by the local cholesterol content of the endosomal membrane. When it is low, NPC1 is ubiquitylated and is associated with the ESCRT complex. Its entry into multivesicular bodies and subsequent delivery to the lysosome might be triggered by cholesterol feeding, which presumably induces de-ubiquitylation of the protein. This sorting might be an obligatory step for the NPC1 function to relocate LDLderived lysosomal cholesterol; further analysis is required to test our hypothesis.
Finally, our findings regarding the NPC2 cells provided an important insight into a functional relationship between NPC1 and NPC2. In cells that lack functional NPC2, ubiquitylation of NPC1 (Fig. 6B ) and endosomal recruitment of SKD1 (Fig.  6C ) occurred under cholesterol-rich conditions, similar to the results obtained in control cells depleted of cholesterol. Thus, under cholesterol-rich conditions, the presence of functional NPC2 was required to prevent NPC1 ubiquitylation and subsequent association with SKD1. NPC2 contains an MD-2-like lipid-recognition domain and binds cholesterol. By analogy to other proteins that contain this domain, it can be postulated that NPC2 extracts membrane-embedded cholesterol and makes it available to other proteins (Inohara and Nunez, 2002) . Therefore, one possible explanation for NPC1 ubiquitylation in NPC2 cells is that cholesterol is unavailable to the membrane domains where NPC1 resides, inducing NPC1 modification that normally takes place under conditions of cholesterol deprivation. This explanation is consistent with the increased protein levels of NPC1 in NPC2 cells (Millat et al., 2001a) , given that NPC1 ubiquitylation caused by cholesterol depletion does not lead to its degradation. Alternatively, it is also possible that NPC2 deficiency acts indirectly, by inducing aberrant compartmentalization of NPC1, and triggering its ubiquitylation. However, this alternative explanation does not agree with our observation that U18666A, which induces aberrant compartmentalization of NPC1, failed to affect its ubiquitylation (Fig. 1F) . We suggest that cholesterol-leveldependent ubiquitylation of NPC1 is a crucial event not only to understand the intracellular sorting of NPC1 but also to unravel the functional relationship between NPC1 and NPC2 in future studies.
Materials and Methods

Materials
Dulbecco's modified Eagle's medium (DMEM), Ham's F12 medium and LipofectAMINE reagent were from Life Technologies. Bovine calf serum (BCS) was from Atlanta Biologicals. Bovine lipoprotein-deficient serum (LPDS), human LDL, anti-Flag M2 agarose and rabbit polyclonal anti-Flag antibody were from Sigma. Rabbit polyclonal anti-NPC1 antibody and mouse monoclonal antibodies against ubiquitin (P4D1), myc, His 6 and GFP were from Santa Cruz Biotech. Rabbit polyclonal anti-SKD1 has been described (Yoshimori et al., 2000) .
Mammalian expression of recombinant proteins
pASC9/Flag-NPC1, an expression plasmid for human NPC1 with a Flag tag inserted in the ClaI site, has been described . pSV-SPORT/NPC1 wild-type (wt) and the P691S mutant were a gift from J. F. Strauss III (Department of Obstetrics and Gynecology, University of Pennsylvania School of Medicine, VA). The PsyI fragment of the Flag-NPC1 cDNA that flanks the Flag epitope was introduced to the corresponding site of pSV-SPORT/NPC1 wt and P691S to generate a Flag-tagged version of the cDNAs. The C-terminal 12 bp were deleted from pSV-SPORT/Flag-NPC1 by PCR-based mutagenesis to generate a cDNA that encoded Flag-NPC1(␦LLNF). An expression plasmid for myc/His 6 -tagged yeast ubiquitin was a gift from R. Kopito (Department of Biological sciences, Stanford University, CA). Expression plasmids for GFP-tagged mouse wt and E235Q mutant SKD1 have been described (Yoshimori et al., 2000) . The entire coding sequence of human SKD1 cDNA (Vps4-B) (Scheuring et al., 2001 ) was obtained by RT-PCR with primers 5Ј-TCCGCCATGTCATCCACTTCG-3Ј and 5Ј-GCTTTTGGCTTAG-CCTTCTTG-3Ј from human skin fibroblasts cDNA. A His 6 epitope was introduced at the C-terminus by PCR and the cDNA was subcloned to the EcoRI/XhoI site of a mammalian expression vector pME18sf. An amino acid substitution E235Q was introduced to pME/His 6 -SKD1 using a Quick Change Site-Directed mutagenesis kit (Stratagene) and was confirmed by direct sequencing. Cells were transfected using LipofectAMINE reagent according to the manufacturer's instructions.
Cell culture COS cells and human skin fibroblasts were maintained in DMEM/10% BCS at 37°C in a humidified atmosphere containing 5% CO 2 . Human skin fibroblasts were from a control human subject (H34), and from patients with NPC1 (UCH) and NPC2 (90031 and 88082) (Millat et al., 2001b) diseases. CHO cells were maintained in F12 medium as above. To deplete cellular cholesterol, cells were cultured for the time indicated in 10% LPDS supplemented with an HMGCoAR inhibitor compactin (2 M) and sodium mevalonate (0.1 mM), which assures cell viability (Ravid et al., 2000) . Where indicated, this cholesterol-depleted medium was supplemented with 20 g/ml LDL. For determination of cholesterol levels, cells in 6-well plates were scraped into PBS and lysed by sonication. Concentrations of protein and total cholesterol in the lysates were determined by using the microprotein assay kit (BioRad) and the Amplex red cholesterol assay kit (Molecular Probes), respectively, according to the manufacturer's instructions.
Immunoprecipitation and affinity purification
All procedures were carried out at 4°C. Cells were washed with PBS and lysed by sonication in buffer A [Tris-HCl 10 mM pH 7.4, NaCl 150 mM, 1 mM EDTA, 1 mM EGTA, 0.5% CHAPS and a protease inhibitor cocktail (Boehringer)]. After a brief centrifugation to remove insoluble material, the supernatant was precleared with an aliquot of agarose beads. For immunoprecipitation of Flag-NPC1, the extracts were incubated for 16 hours with anti-Flag M2 agarose beads, washed with buffer A, followed by elution of bound proteins by heating at 65°C for 10 minutes in SDS-PAGE sample buffer. SDS-PAGE, western transfer and immunoblotting were carried out as previously described . The blot was developed using an ECL kit (Amersham Pharmacia). For immunoprecipitation of ubiquitylated proteins, cell extracts were incubated with anti-ubiquitin P4D1 antibodies for 16 hours and the immunoprecipitates were collected with protein A sepharose. For affinity purification of His 6 -tagged proteins (myc/His 6 -ubiquitin or His 6 -SKD1), cell extracts were incubated for 16 hours with TALON metal affinity resin (Clontech). Bound proteins were analyzed as described above.
Cell fractionation
Cells were harvested in Tris-buffered saline (TBS; Tris-HCl 10 mM pH 7.4, NaCl 150 mM) supplemented with a protease inhibitor cocktail and lysed by sonication. The cell lysates were incubated on ice for 30 minutes in TBS supplemented with 1% Triton X-100 and 0.1% SDS to give total extracts. To prepare 1% Triton X-100-soluble and Triton X-100-insoluble fractions, the cell lysates were incubated in TBS + 1% Triton X-100 and, after centrifugation at 100,000 g for 30 minutes, the pellet was suspended in TBS + 1% Triton X-100 + 0.1% SDS. For subcellular fractionation, membranes were fractionated by using an Opti-prep gradient (Axis-Shield) as described (Lin et al., 2004) . Briefly, cells were homogenized with a potter homogenizer in ice-cold buffer (Hepes 10 mM pH 7.0, 1 mM EDTA, 1 mM EGTA supplemented with a protease inhibitor cocktail). After centrifugation at 100,000 g for 1 hour at 4°C, the supernatant was discarded and the pellet was resuspended in the same buffer, overlaid onto an Opti-prep gradient and centrifuged at 100,000 g for 16 hours at 4°C. The top 12 fractions of the gradient were recovered and numbered accordingly.
Immunofluorescence
All procedures were carried out at room temperature. Cells were fixed for 2 minutes with acetone:methanol (1:1 v/v) and incubated for 30 minutes in PBS + 1% bovine serum albumin (BSA). They were then incubated for 1 hour with anti-Flag antibody or anti-His 6 antibody in PBS + 1% BSA. Bound antibodies were visualized with an Alexa Fluor 546-conjugated secondary antibody and images were obtained using a BioRad MRC1024 confocal laser-scanning microscope.
Bacterial expression of GST-SKD1 and in vitro binding assays
The EcoRI/XhoI fragment of pME/SKD1 was transferred to pGEX-6P (Amersham Pharmacia). DH5␣ competent cells were transformed with the plasmid and protein expression was induced with 1 mM IPTG at 37°C for 3 hours. GST-SKD1 was recovered from bacterial pellets in 8 M urea, dialyzed against TBS and immobilized on glutathione sepharose. For in vitro binding assays, GST-SKD1 glutathione sepharose was incubated with 0.5% CHAPS extracts from Flag-NPC1-expressing cells at 4°C for 2 hours, in the absence or presence of ADP, ATP or ATP␥s (all at 0.5 mM). The sepharose resin was washed with TBS + 0.5% CHAPS and bound proteins were eluted with glutathione and analyzed by SDS-PAGE followed by immunoblotting with anti-Flag antibody.
